Prostate cancer patients inform health economics research
CHÉOS Scientists are testing the cost-effectiveness of adding a new blood test to improve prostate cancer screening
Read MoreFebruary 25, 2021
CHÉOS Scientists are testing the cost-effectiveness of adding a new blood test to improve prostate cancer screening
Read More
In recognition of Rare Disease Day, CHÉOS Scientist Dr. Larry Lynd shares an insight into his work investigating the diagnosis, treatment, and management of rare diseases
Read More
New clinical trial results co-authored by CHÉOS’ Dr. Rob Stenstrom explore how diagnostic testing accuracy is affected by early sepsis treatment.
Read More